BioPharmX Corporation. Common

(BPMX)

By |

Profile

BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Its objective is to develop products that treat health or age-related conditions that are not presently being addressed or treated or are currently treated with drug therapies or drug delivery approaches that are sub-optimal. The company has developed its product portfolio using its proprietary drug delivery technologies, including delivery mechanisms for antibiotics, biologic materials, and molecular iodine. Its products include VI2OLET iodine dietary supplement, two clinical-stage product candidates, BPX01 and BPX03 and one development-stage product candidate, BPX02.

Contact Information

Website: www.biopharmx.com
Email: investors@biopharmx.com
Main Phone: +1 650 889-5020
Address: 1505 Adams Drive
Address 2: Suite D
State: CA
City / Town: Menlo Park
Country: USA
Postal Code: 94025

Issuer Information

Exchange: AMX
CEO: David S. Tierney
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.12 $ -0.0003 (-0.26%)
Last Price 0.12 Change $ -0.0003 Change % -0.26 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.12 High 0.12 Low 0.12 Prev Close 0.12
Last Trade Volume 2 mi 52 Wk Hi 0.38 52 Wk Low 0.10
Market Cap 24.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 212,815,296.00 EPS (TTM) -0.08 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 4
Number of Buys 0 4
Number of Sells 0 0
Net Activity 0 2950000
Last 10 Buys Shares
Stephen Morlock 1,000
Stephen Morlock 1,000
Stephen Morlock 1,000
Stephen Morlock 1,000
Stephen Morlock 1,000
Stephen Morlock 1,000
Stephen Morlock 1,000
Stephen Morlock 1,000
Stephen Morlock 1,000
Stephen Morlock 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 0.6 0.6 0.6 0.6
Mean Target Price Estimate 1.7 1.7 1.7 1.7
Standard Deviation 1.21 1.21 1.21 1.21
Date of Most Recent Estimate 05/07/18 05/07/18 05/07/18 05/07/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1